TriNetX Appoints New Members to Board of Directors
February 22, 2021 at 09:00 AM EST
CAMBRIDGE, Mass., Feb. 22, 2021 /PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the appointment of four new members to the company's board of directors including the appointment of former Pfizer CEO and Chairman Ian Read as the company's new Chairman of the Board. The changes to the TriNetX board follows the acquisition of a majority stake in the company by The Carlyle Group in October.
In addition to Mr. Read, the new members of the TriNetX board are Steve Wise, Joe Bress, and Ashley Evans from Carlyle. They join current board members Gadi Lachman, Jeff Margolis, and Leslie Henshaw, and board observers Joe Volpe and Ryohei (Rio) Umezawa.
"We are excited to welcome Ian Read as our new Chairman of the Board," said Gadi Lachman, CEO of TriNetX. "Ian brings a wealth of industry experience to the company as do our other new board members. We look forward to working together to grow the company and improve our ability to positively impact the research community."
New board member bios:
The Carlyle Group
View original content to download multimedia:http://www.prnewswire.com/news-releases/trinetx-appoints-new-members-to-board-of-directors-301232090.html
SOURCE TriNetX, LLC.